Fatty Liver Disease,An Issue of Gastroenterology Clinics of North America
Seiten
2020
Elsevier - Health Sciences Division (Verlag)
978-0-323-68203-9 (ISBN)
Elsevier - Health Sciences Division (Verlag)
978-0-323-68203-9 (ISBN)
Together with Consulting Editor Dr. Alan Buchman, Drs. Arun J. Sanyal and Mohammad Siddiqui have put together a comprehensive issue devoted to fatty liver disease for the gastroenterologist. Expert authors have contributed clinical review articles on the following topics: Burden of disease due to NAFLD; Genetic risk factors and disease modifiers of NASH; How to identify the patient with NASH who will progress to cirrhosis; Similarities and Differences between cirrhosis due to NASH versus other etiologies; Impications of NASH as the etiology of end stage liver disease prior to and after liver transplantation; Why do lifestyle recommendations fail in most patients; Rational nutritional therapeutics for NAFLD; Recruitment and retention strategies in long-term trials for NASH; Managing extrahepatic comorbidities in NAFLD; The current status of noninvasive tools for the assessment of NAFLD; and Pharmacological Treatment strategies for NASH. Readers will come away with the information they need to improve outcomes in patients with fatty liver disease.
Erscheinungsdatum | 19.02.2020 |
---|---|
Reihe/Serie | The Clinics: Internal Medicine |
Verlagsort | Philadelphia |
Sprache | englisch |
Maße | 152 x 229 mm |
Gewicht | 430 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie |
Medizinische Fachgebiete ► Innere Medizin ► Hepatologie | |
ISBN-10 | 0-323-68203-0 / 0323682030 |
ISBN-13 | 978-0-323-68203-9 / 9780323682039 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 76,00